Injectable nano-suspension will lead complex generics sales through 2036 with 63.0% of the form segment in 2026. The market was valued at USD 90.68 billion in 2025 and is expected to be worth USD 213.60 billion by 2036, creating an incremental opportunity of USD 115.57 billion between 2026 and 2036.